Beacon Therapeutics
在场
Beacon Therapeutics 的所有者是 Syncona.
是其中之一......
Syncona 是一家在股票代码 SYNC (GB) 下上市的公司。
Syncona 在 3 个国家有直接业务。Syncona 拥有 13家子公司，其中包括 Achilles Therapeutics、Anaveon 和 Autolus Therapeutics。
他们在：
涉及Syncona的并购和融资。
- Syncona has announced the acquisition of Beacon Therapeutics (公布2022十月28号).
高管
查看带有其 7 名主要高管的组织结构图
Beacon Therapeutics 搜索最多的简介
- Dave Fellow, Chief Executive Officer
- Abraham Scaria, Chief Science Officer
- Nadia Waheed, Chief Medical Officer
高管在Beacon Therapeutics变化
- Prithvi Gandhi已作为Executive Vice President and Chief Financial Officer加入公司 (新闻发布的2024四月23号).
创建提醒
跟踪 Beacon Therapeutics 的高管变动
生物技术
Syncona 拥有 2,282 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Beacon Therapeutics 的最新新闻稿
- Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production - Beacon Therapeutics
- Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Phase 2 SKYLINE Trial - Beacon Therapeutics
- Beacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa - Beacon Therapeutics
- Beacon Announces Unmasked Three-Month Data from Phase 2 SKYLINE Trial of AGTC-501 for X- Linked Retinitis Pigmentosa - Beacon Therapeutics
- News and Events - Beacon Therapeutics
- Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa Phase 2 Randomized, Controlled, Multicenter Clinical Trial (Skyline) 3-Month Results - Beacon Therapeutics
- Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa (XLRP) Phase 1/2 Multicenter Study (Horizon): 24-Month Interim Safety Results - Beacon Therapeutics
- Beacon Therapeutics Launch - Beacon Therapeutics
- AGTC to Participate in Upcoming Investor Conferences | Applied Genetic Technologies Corporation
- News | Applied Genetic Technologies Corporation
- View more press releases Close
通过电子邮件
